Particularly high volume was seen for the $45 strike call option expiring August 16, 2024, with 3,008 contracts trading so far today, representing approximately 300,800 underlying shares of APLS.

Especially high volume was seen for the $25 strike call option expiring January 19, 2024, with 6,500 contracts trading so far today, representing approximately 650,000 underlying shares of APLS.

Fintel reports that on October 16, 2024, William Blair initiated coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a Outperform recommendation. Analyst Price Forecast Suggests 150.89% ...

Apellis Pharmaceuticals APLS announced that the FDA has accepted its supplemental new drug application (sNDA) seeking the label expansion of Empaveli (pegcetacoplan) for two rare and severe kidney ...